Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 12, 2018 08:00 ET | Source: Biofrontera AG

Biofrontera files lawsuit against W.K.T. Zours, Deutsche Balaton AG and further defendants

Leverkusen, Germany, June 12, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced that...
May 30, 2018 08:00 ET | Source: Biofrontera AG

Biofrontera Reports First Quarter 2018 Financial Results

Leverkusen, Germany, May 30, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its...
April 30, 2018 08:00 ET | Source: Biofrontera AG

Biofrontera Reports Full Year 2017 Financial Results

Leverkusen, Germany, April 30, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (“Biofrontera” or the “Company”), an international biopharmaceutical...
April 12, 2018 10:53 ET | Source: Biofrontera AG

Biofrontera announces preliminary unaudited sales revenues for the 1st Quarter 2018

Leverkusen, Germany, April 12, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ:BFRA) (ISIN: DE0006046113), the specialist for the treatment of sun-induced skin cancer, today announced preliminary...
March 15, 2018 10:15 ET | Source: Biofrontera AG

Biofrontera AG Announces Partial Waiver of Lock-Up Agreement

LEVERKUSEN, Germany, March 15, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ:BFRA) (Frankfurt Stock Exchange:B8F) (the “Company”) announced today that The Benchmark Company, LLC, the managing...
February 16, 2018 16:05 ET | Source: Biofrontera AG

Biofrontera AG Announces Closing of $US12.9 Million Firm Commitment Initial Public Offering of American Depositary Shares

LEVERKUSEN, Germany, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ:BFRA) (Frankfurt Stock Exchange:B8F) (“Biofrontera” or the “Company”), an international biopharmaceutical company, today...
February 13, 2018 19:00 ET | Source: Biofrontera AG

Biofrontera AG Announces Pricing of US$12 Million Firm Commitment Public Offering of American Depositary Shares and NASDAQ Listing

LEVERKUSEN, Germany, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ:BFRA) (Frankfurt Stock Exchange:B8F) (“Biofrontera” or the “Company”), an international biopharmaceutical company, today...
April 15, 2016 02:04 ET | Source: Biofrontera AG

Biofrontera AG: Biofrontera Reports Full Year 2015 Financial Results

LEVERKUSEN, Germany, April 15, 2016 (GLOBE NEWSWIRE) -- Biofrontera AG (FSE: B8F), the specialist for sun-induced skin cancer, today reported its full year 2015 financial results for the year ended 31...
April 07, 2016 08:06 ET | Source: Biofrontera AG

Biofrontera AG: Notice of Annual Results 2016

LEVERKUSEN, Germany, April 7, 2016 (GLOBE NEWSWIRE) -- Biofrontera AG (AIM:B8F), the specialist for sun-induced skin cancer, will be announcing its financial results for the twelve-month period ended...
April 04, 2016 07:04 ET | Source: Biofrontera AG

Biofrontera Announces NDA Progress Update for BF-200 ALA

FDA issued suggested labeling for BF-200 ALA for treatment of actinic keratosis (AK) FDA has not requested any further data NDA on track LEVERKUSEN, Germany, April 4, 2016 (GLOBE...